190 related articles for article (PubMed ID: 28819447)
1. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.
Yap ML; McFadyen JD; Wang X; Zia NA; Hohmann JD; Ziegler M; Yao Y; Pham A; Harris M; Donnelly PS; Hogarth PM; Pietersz GA; Lim B; Peter K
Theranostics; 2017; 7(10):2565-2574. PubMed ID: 28819447
[No Abstract] [Full Text] [Related]
2. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.
Yap ML; McFadyen JD; Wang X; Ziegler M; Chen YC; Willcox A; Nowell CJ; Scott AM; Sloan EK; Hogarth PM; Pietersz GA; Peter K
Theranostics; 2019; 9(4):1154-1169. PubMed ID: 30867822
[No Abstract] [Full Text] [Related]
3. Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.
Guo S; Shen S; Wang J; Wang H; Li M; Liu Y; Hou F; Liao Y; Bin J
Theranostics; 2015; 5(4):418-30. PubMed ID: 25699100
[TBL] [Abstract][Full Text] [Related]
4. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice.
Wang X; Hagemeyer CE; Hohmann JD; Leitner E; Armstrong PC; Jia F; Olschewski M; Needles A; Peter K; Ahrens I
Circulation; 2012 Jun; 125(25):3117-26. PubMed ID: 22647975
[TBL] [Abstract][Full Text] [Related]
5. In vivo ultrasound molecular imaging of inflammatory thrombosis in arteries with cyclic Arg-Gly-Asp-modified microbubbles targeted to glycoprotein IIb/IIIa.
Wu W; Wang Y; Shen S; Wu J; Guo S; Su L; Hou F; Wang Z; Liao Y; Bin J
Invest Radiol; 2013 Nov; 48(11):803-12. PubMed ID: 23857134
[TBL] [Abstract][Full Text] [Related]
6. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
[TBL] [Abstract][Full Text] [Related]
7. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR
Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688
[TBL] [Abstract][Full Text] [Related]
8. Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets.
Ziegler M; Alt K; Paterson BM; Kanellakis P; Bobik A; Donnelly PS; Hagemeyer CE; Peter K
Sci Rep; 2016 Dec; 6():38161. PubMed ID: 27909290
[TBL] [Abstract][Full Text] [Related]
9. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
Hohmann JD; Wang X; Krajewski S; Selan C; Haller CA; Straub A; Chaikof EL; Nandurkar HH; Hagemeyer CE; Peter K
Blood; 2013 Apr; 121(16):3067-75. PubMed ID: 23380744
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease.
Ta HT; Prabhu S; Leitner E; Jia F; von Elverfeldt D; Jackson KE; Heidt T; Nair AK; Pearce H; von Zur Muhlen C; Wang X; Peter K; Hagemeyer CE
Circ Res; 2011 Aug; 109(4):365-73. PubMed ID: 21700932
[TBL] [Abstract][Full Text] [Related]
11. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis.
Günther F; Heidt T; Kramer M; Khanicheh E; Klibanov AL; Geibel-Zehender A; Ferrante EA; Hilgendorf I; Wolf D; Zirlik A; Reinöhl J; Bode C; Peter K; Kaufmann BA; Mühlen CVZ
Sci Rep; 2017 Nov; 7(1):14898. PubMed ID: 29097799
[TBL] [Abstract][Full Text] [Related]
13. Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging.
von Elverfeldt D; Maier A; Duerschmied D; Braig M; Witsch T; Wang X; Mauler M; Neudorfer I; Menza M; Idzko M; Zirlik A; Heidt T; Bronsert P; Bode C; Peter K; von Zur Muhlen C
Circulation; 2014 Aug; 130(8):676-87. PubMed ID: 24951772
[TBL] [Abstract][Full Text] [Related]
14. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
15. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
Nakatanl S; Hato T; Minamoto Y; Fujita S
Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
[TBL] [Abstract][Full Text] [Related]
17. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.
von zur Muhlen C; Peter K; Ali ZA; Schneider JE; McAteer MA; Neubauer S; Channon KM; Bode C; Choudhury RP
J Vasc Res; 2009; 46(1):6-14. PubMed ID: 18515970
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury.
Ziegler M; Wang X; Lim B; Leitner E; Klingberg F; Ching V; Yao Y; Huang D; Gao XM; Kiriazis H; Du XJ; Haigh JJ; Bobik A; Hagemeyer CE; Ahrens I; Peter K
Theranostics; 2017; 7(13):3192-3206. PubMed ID: 28900504
[TBL] [Abstract][Full Text] [Related]
19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
20. Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets.
Alt K; Paterson BM; Ardipradja K; Schieber C; Buncic G; Lim B; Poniger SS; Jakoby B; Wang X; O'Keefe GJ; Tochon-Danguy HJ; Scott AM; Ackermann U; Peter K; Donnelly PS; Hagemeyer CE
Mol Pharm; 2014 Aug; 11(8):2855-63. PubMed ID: 24999533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
